Sclerosis, Progressive Systemic Completed Phase 2 Trials for Treprostinil (DB00374)

Also known as: Systemic Sclerosis / Sclerosis, Systemic / Progressive systemic sclerosis / Scleroderma, Systemic / Scleroderma

IndicationStatusPhase
DBCOND0080156 (Sclerosis, Progressive Systemic)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00775463Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil DiethanolamineTreatment